Research programme: lorazepam transmucosal spray - EastGate BiotechAlternative Names: Lorazepam transmucosal oral spray - EastGate Biotech
Latest Information Update: 21 Jan 2016
At a glance
- Originator EastGate Acquisitions
- Developer EastGate Biotech
- Class Antiemetics; Anxiolytics; Benzodiazepinones; Hypnosedatives; Small molecules
- Mechanism of Action GABA A receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Seizures